Published in Br J Pharmacol on March 12, 2007
Hydrogen sulfide in biochemistry and medicine. Antioxid Redox Signal (2012) 1.64
Thrombospondin 1 and vasoactive agents indirectly alter tumor blood flow. Neoplasia (2008) 0.92
Dithiolethione modified valproate and diclofenac increase E-cadherin expression and decrease proliferation of non-small cell lung cancer cells. Lung Cancer (2009) 0.89
Molecular regulation of tumor angiogenesis and perfusion via redox signaling. Chem Rev (2009) 0.89
Dithiolethione compounds inhibit Akt signaling in human breast and lung cancer cells by increasing PP2A activity. Oncogene (2009) 0.89
Arylthioamides as H2S Donors: l-Cysteine-Activated Releasing Properties and Vascular Effects in Vitro and in Vivo. ACS Med Chem Lett (2013) 0.86
Hydrogen sulfide: physiological properties and therapeutic potential in ischaemia. Br J Pharmacol (2015) 0.86
Comprehensive characterization of heat shock protein 27 phosphorylation in human endothelial cells stimulated by the microbial dithiole thiolutin. J Proteome Res (2008) 0.85
Differential effects of ABT-510 and a CD36-binding peptide derived from the type 1 repeats of thrombospondin-1 on fatty acid uptake, nitric oxide signaling, and caspase activation in vascular cells. Biochem Pharmacol (2007) 0.84
New histone deacetylase inhibitors as potential therapeutic tools for advanced prostate carcinoma. J Cell Mol Med (2008) 0.84
Thiolutin inhibits endothelial cell adhesion by perturbing Hsp27 interactions with components of the actin and intermediate filament cytoskeleton. Cell Stress Chaperones (2009) 0.83
Preclinical studies identify novel targeted pharmacological strategies for treatment of human malignant pleural mesothelioma. Br J Pharmacol (2012) 0.83
Protein expression profiling in the spectrum of renal cell carcinomas. J Cancer (2010) 0.81
Effects of the histone deacetylase inhibitor valproic acid on human pericytes in vitro. PLoS One (2011) 0.81
Novel dithiolethione-modified nonsteroidal anti-inflammatory drugs in human hepatoma HepG2 and colon LS180 cells. Clin Cancer Res (2009) 0.80
Hydrogen sulphide-releasing diclofenac derivatives inhibit breast cancer-induced osteoclastogenesis in vitro and prevent osteolysis ex vivo. Br J Pharmacol (2012) 0.78
Role of Hydrogen Sulfide in Ischemia-Reperfusion Injury. Oxid Med Cell Longev (2015) 0.78
Synthesis of Amino-ADT Provides Access to Hydrolytically Stable Amide-Coupled Hydrogen Sulfide Releasing Drug Targets. Synlett (2016) 0.76
Sodium valproate inhibits the growth of human cholangiocarcinoma in vitro and in vivo. Gastroenterol Res Pract (2013) 0.76
International Union of Basic and Clinical Pharmacology. CII: Pharmacological Modulation of H2S Levels: H2S Donors and H2S Biosynthesis Inhibitors. Pharmacol Rev (2017) 0.75
Improved patch-clamp techniques for high-resolution current recording from cells and cell-free membrane patches. Pflugers Arch (1981) 134.60
Molecular determinants of state-dependent block of Na+ channels by local anesthetics. Science (1994) 5.62
Structure and function of voltage-sensitive ion channels. Science (1988) 4.48
Sodium channel blockers identify risk for sudden death in patients with ST-segment elevation and right bundle branch block but structurally normal hearts. Circulation (2000) 3.99
Ca2+ signalling between single L-type Ca2+ channels and ryanodine receptors in heart cells. Nature (2001) 3.79
Cellular and molecular biology of voltage-gated sodium channels. Physiol Rev (1992) 3.65
International Union of Pharmacology. LIII. Nomenclature and molecular relationships of voltage-gated potassium channels. Pharmacol Rev (2005) 3.50
Voltage-clamp experiments in normal and denervated mammalian skeletal muscle fibres. J Physiol (1980) 2.91
Molecular mechanisms of neurotoxin action on voltage-gated sodium channels. Biochimie (2000) 2.85
Molecular mechanisms of local anesthesia: a review. Anesthesiology (1990) 2.82
Voltage-gated ion channels and hereditary disease. Physiol Rev (1999) 2.76
A unique role for the S4 segment of domain 4 in the inactivation of sodium channels. J Gen Physiol (1996) 2.34
Lateral distribution of sodium and potassium channels in frog skeletal muscle: measurements with a patch-clamp technique. J Physiol (1983) 2.18
The ajmaline challenge in Brugada syndrome: diagnostic impact, safety, and recommended protocol. Eur Heart J (2003) 2.10
A critical role for transmembrane segment IVS6 of the sodium channel alpha subunit in fast inactivation. J Biol Chem (1995) 1.95
A quantitative study of potassium channel kinetics in rat skeletal muscle from 1 to 37 degrees C. J Gen Physiol (1983) 1.88
Kv2.1/Kv9.3, a novel ATP-dependent delayed-rectifier K+ channel in oxygen-sensitive pulmonary artery myocytes. EMBO J (1997) 1.84
A mutation in segment IVS6 disrupts fast inactivation of sodium channels. Proc Natl Acad Sci U S A (1994) 1.70
Voltage clamp of rat and human skeletal muscle: measurements with an improved loose-patch technique. J Physiol (1984) 1.46
Na channel distribution in vertebrate skeletal muscle. J Gen Physiol (1986) 1.32
Crucial role of sodium channel fast inactivation in muscle fibre inexcitability in a rat model of critical illness myopathy. J Physiol (2003) 1.29
Effects of temperature on slow and fast inactivation of rat skeletal muscle Na(+) channels. Am J Physiol (1999) 1.20
Skeletal muscle disuse induces fibre type-dependent enhancement of Na(+) channel expression. Brain (2001) 1.06
Calcium currents during contraction and shortening in enzymatically isolated murine skeletal muscle fibres. J Physiol (1999) 1.03
Primary structure and functional expression of a cGMP-gated potassium channel. Proc Natl Acad Sci U S A (1995) 1.03
An evolutionarily conserved network of amino acids mediates gating in voltage-dependent potassium channels. J Mol Biol (2004) 1.00
Cooperative effect of S4-S5 loops in domains D3 and D4 on fast inactivation of the Na+ channel. J Physiol (2004) 0.93
Critical illness myopathy serum fractions affect membrane excitability and intracellular calcium release in mammalian skeletal muscle. J Neurol (2004) 0.91
A novel nonsense mutation in the SCN5A gene leads to Brugada syndrome and a silent gene mutation carrier state. Can J Cardiol (2005) 0.89
Genomic organization, chromosomal localization, tissue distribution, and biophysical characterization of a novel mammalian Shaker-related voltage-gated potassium channel, Kv1.7. J Biol Chem (1998) 0.88
Electrophysiological and haemodynamic effects of lidocaine and ajmaline in the management of sustained ventricular tachycardia. Eur Heart J (1992) 0.86
Molecular cloning and expression of a Kv1.1-like potassium channel from the electric organ of Electrophorus electricus. J Membr Biol (2003) 0.84
Membrane ion conductances of mammalian skeletal muscle in the post-decompression state after high-pressure treatment. J Membr Biol (2002) 0.81
Prolonged high-pressure treatments in mammalian skeletal muscle result in loss of functional sodium channels and altered calcium channel kinetics. Cell Biochem Biophys (2006) 0.80
Class Ia anti-arrhythmic drug ajmaline blocks HERG potassium channels: mode of action. Naunyn Schmiedebergs Arch Pharmacol (2004) 0.80
Effect of ajmaline on action potential and ionic currents in rat ventricular myocytes. Gen Physiol Biophys (2005) 0.79
Characterization of a P-type calcium current in a crayfish motoneuron and its selective modulation by impulse activity. J Neurophysiol (1997) 0.79
Blockade by antiarrhythmic drugs of glibenclamide-sensitive K+ channels in Xenopus oocytes. Br J Pharmacol (1992) 0.79
Effect of ajmaline on transient outward current in rat ventricular myocytes. Gen Physiol Biophys (2005) 0.78
Differential effects of alkaloids on sodium currents of isolated single skeletal muscle fibers. FEBS Lett (1998) 0.78
Involvement of different S4 parts in the voltage dependency of Na channel gating. J Membr Biol (1992) 0.77
Effects of ajmaline on non-sodium ionic currents in guinea pig ventricular myocytes. Jpn Heart J (1995) 0.77
Dual action of prajmalium on the Ca currents in frog isolated cardiomyocytes. J Mol Cell Cardiol (1991) 0.77
Protective effects of antiarrhythmic agents against anoxic injury in CNS white matter. J Cereb Blood Flow Metab (1995) 0.77
Effect of ajmaline on sustained ventricular tachycardia induced by programmed electrical stimulation in conscious dogs after myocardial infarction. Naunyn Schmiedebergs Arch Pharmacol (1993) 0.76
SGD: Saccharomyces Genome Database. Nucleic Acids Res (1998) 20.26
A rapid, simple spectrophotometric method for simultaneous detection of nitrate and nitrite. Nitric Oxide (2001) 6.48
Establishment and identification of small cell lung cancer cell lines having classic and variant features. Cancer Res (1985) 5.02
Predisposing factors for severe, uncontrolled hypertension in an inner-city minority population. N Engl J Med (1992) 4.79
Bombesin-like peptides can function as autocrine growth factors in human small-cell lung cancer. Nature (1985) 4.47
Many pulmonary pathogenic bacteria bind specifically to the carbohydrate sequence GalNAc beta 1-4Gal found in some glycolipids. Proc Natl Acad Sci U S A (1988) 3.83
Thrombospondin binds falciparum malaria parasitized erythrocytes and may mediate cytoadherence. Nature (1985) 3.53
Multiferroic BaTiO3-CoFe2O4 Nanostructures. Science (2004) 3.49
"NONOates" (1-substituted diazen-1-ium-1,2-diolates) as nitric oxide donors: convenient nitric oxide dosage forms. Methods Enzymol (1996) 3.34
Complexes of .NO with nucleophiles as agents for the controlled biological release of nitric oxide. Vasorelaxant effects. J Med Chem (1991) 3.27
Dynamics and folding of single two-stranded coiled-coil peptides studied by fluorescent energy transfer confocal microscopy. Proc Natl Acad Sci U S A (2000) 2.75
Improved DNA: liposome complexes for increased systemic delivery and gene expression. Nat Biotechnol (1997) 2.52
Pseudomonas aeruginosa and Pseudomonas cepacia isolated from cystic fibrosis patients bind specifically to gangliotetraosylceramide (asialo GM1) and gangliotriaosylceramide (asialo GM2). Arch Biochem Biophys (1988) 2.49
Endostatin induces endothelial cell apoptosis. J Biol Chem (1999) 2.49
Autoxidation kinetics of aqueous nitric oxide. FEBS Lett (1993) 2.47
tA single amino acid difference distinguishes resistant and susceptible alleles of the rice blast resistance gene Pi-ta. Plant Cell (2000) 2.45
Fluorescence and photobleaching dynamics of single light-harvesting complexes. Proc Natl Acad Sci U S A (1997) 2.42
Correlates of nonadherence to hypertension treatment in an inner-city minority population. Am J Public Health (1992) 2.33
Regulation of transforming growth factor-beta activation by discrete sequences of thrombospondin 1. J Biol Chem (1995) 2.28
Glucose deprivation-induced oxidative stress in human tumor cells. A fundamental defect in metabolism? Ann N Y Acad Sci (2000) 2.25
Transfection of thrombospondin 1 complementary DNA into a human breast carcinoma cell line reduces primary tumor growth, metastatic potential, and angiogenesis. Cancer Res (1994) 2.20
Reactivity of small thiolate anions and cysteine-25 in papain toward methyl methanethiosulfonate. Biochemistry (1986) 2.20
Nitric oxide potentiates hydrogen peroxide-induced killing of Escherichia coli. J Exp Med (1995) 2.14
Inhibition of angiogenesis by thrombospondin-1 is mediated by 2 independent regions within the type 1 repeats. Circulation (1999) 2.11
Increased manganese superoxide dismutase expression suppresses the malignant phenotype of human melanoma cells. Proc Natl Acad Sci U S A (1993) 2.08
High levels of intracellular bombesin characterize human small-cell lung carcinoma. Science (1981) 2.07
Genesis, a winged helix transcriptional repressor with expression restricted to embryonic stem cells. J Biol Chem (1996) 2.02
Canstatin, a novel matrix-derived inhibitor of angiogenesis and tumor growth. J Biol Chem (2000) 1.97
Nitric oxide. I. Physiological chemistry of nitric oxide and its metabolites:implications in inflammation. Am J Physiol (1999) 1.93
The platelet glycoprotein thrombospondin binds specifically to sulfated glycolipids. J Biol Chem (1985) 1.90
Neutrophils employ the myeloperoxidase system to generate antimicrobial brominating and chlorinating oxidants during sepsis. Proc Natl Acad Sci U S A (2001) 1.84
Thrombospondin 1 and type I repeat peptides of thrombospondin 1 specifically induce apoptosis of endothelial cells. Cancer Res (1997) 1.81
Platelet thrombospondin mediates attachment and spreading of human melanoma cells. J Cell Biol (1987) 1.81
Prenatal nicotine increases pulmonary alpha7 nicotinic receptor expression and alters fetal lung development in monkeys. J Clin Invest (1999) 1.77
Adhesion of Mycoplasma pneumoniae to sulfated glycolipids and inhibition by dextran sulfate. J Biol Chem (1989) 1.76
Energy transfer and trapping in the photosystem I core antenna. A temperature study. Biophys J (1992) 1.76
Cell transplantation as future therapy for cardiovascular disease?: A workshop of the National Heart, Lung, and Blood Institute. Circulation (2000) 1.66
Nitroxyl anion exerts redox-sensitive positive cardiac inotropy in vivo by calcitonin gene-related peptide signaling. Proc Natl Acad Sci U S A (2001) 1.63
Opposite effects of nitric oxide and nitroxyl on postischemic myocardial injury. Proc Natl Acad Sci U S A (1999) 1.63
Electric field-induced magnetization switching in epitaxial columnar nanostructures. Nano Lett (2005) 1.61
Transforming growth factor-beta 1 and its receptors in human lung cancer and mouse lung carcinogenesis. Exp Lung Res (2000) 1.58
Expression of the extracellular matrix molecule thrombospondin inversely correlates with malignant progression in melanoma, lung and breast carcinoma cell lines. Int J Cancer (1994) 1.57
Thrombospondin-induced tumor cell migration: haptotaxis and chemotaxis are mediated by different molecular domains. J Cell Biol (1987) 1.56
Anti-thrombotic effects of a nitric oxide-releasing, gastric-sparing aspirin derivative. J Clin Invest (1995) 1.55
Selective stimulation of small cell lung cancer clonal growth by bombesin and gastrin-releasing peptide. Cancer Res (1987) 1.53
Modulation of superoxide-dependent oxidation and hydroxylation reactions by nitric oxide. J Biol Chem (1996) 1.53
Cell surface glypicans are low-affinity endostatin receptors. Mol Cell (2001) 1.51
Reaction of superoxide and nitric oxide with peroxynitrite. Implications for peroxynitrite-mediated oxidation reactions in vivo. J Biol Chem (2001) 1.47
Phenotypic changes induced in human breast cancer cells by overexpression of manganese-containing superoxide dismutase. Oncogene (1995) 1.46
Endostatin: yeast production, mutants, and antitumor effect in renal cell carcinoma. Cancer Res (1999) 1.45
Characterization of collagen gel solutions and collagen matrices for cell culture. Biomaterials (2001) 1.44
Dietary flavonols quercetin and kaempferol are ligands of the aryl hydrocarbon receptor that affect CYP1A1 transcription differentially. Biochem J (1999) 1.42
Chemistry of the diazeniumdiolates. 2. Kinetics and mechanism of dissociation to nitric oxide in aqueous solution. J Am Chem Soc (2001) 1.42
Class I and III polyhydroxyalkanoate synthases from Ralstonia eutropha and Allochromatium vinosum: characterization and substrate specificity studies. Arch Biochem Biophys (2001) 1.42
Cell contact-dependent activation of alpha3beta1 integrin modulates endothelial cell responses to thrombospondin-1. Mol Biol Cell (2000) 1.41
Deletion of PBP/PPARBP, the gene for nuclear receptor coactivator peroxisome proliferator-activated receptor-binding protein, results in embryonic lethality. J Biol Chem (2000) 1.39
Effects of autonomic nervous system on gastric damage by ethanol in the rat. Dig Dis Sci (1989) 1.38
Modulation of endothelial cell proliferation, adhesion, and motility by recombinant heparin-binding domain and synthetic peptides from the type I repeats of thrombospondin. J Cell Biochem (1993) 1.37
Metabolic oxidative stress activates signal transduction and gene expression during glucose deprivation in human tumor cells. Free Radic Biol Med (1999) 1.35
Resveratrol inhibits transcription of CYP1A1 in vitro by preventing activation of the aryl hydrocarbon receptor. Cancer Res (1998) 1.32
Huge critical current density and tailored superconducting anisotropy in SmFeAsO₀.₈F₀.₁₅ by low-density columnar-defect incorporation. Nat Commun (2013) 1.31
Pro-adhesive and chemotactic activities of thrombospondin-1 for breast carcinoma cells are mediated by alpha3beta1 integrin and regulated by insulin-like growth factor-1 and CD98. J Biol Chem (1999) 1.29
Cloning, expression, and in vitro activity of human endostatin. Biochem Biophys Res Commun (1999) 1.28
Vildagliptin plus metformin combination therapy provides superior glycaemic control to individual monotherapy in treatment-naive patients with type 2 diabetes mellitus. Diabetes Obes Metab (2009) 1.28
NO synthase 2 (NOS2) deletion promotes multiple pathologies in a mouse model of Alzheimer's disease. Proc Natl Acad Sci U S A (2006) 1.27
Heparin-binding peptides from the type I repeats of thrombospondin. Structural requirements for heparin binding and promotion of melanoma cell adhesion and chemotaxis. J Biol Chem (1992) 1.27
Targeting SET/I(2)PP2A oncoprotein functions as a multi-pathway strategy for cancer therapy. Oncogene (2011) 1.26
NO-naproxen vs. naproxen: ulcerogenic, analgesic and anti-inflammatory effects. Aliment Pharmacol Ther (1997) 1.26
Unique oxidative mechanisms for the reactive nitrogen oxide species, nitroxyl anion. J Biol Chem (2000) 1.25
Disease-associated mutations in cytoplasmic loops 1 and 2 of cystic fibrosis transmembrane conductance regulator impede processing or opening of the channel. Biochemistry (1997) 1.25
Convenient colorimetric and fluorometric assays for S-nitrosothiols. Anal Biochem (1996) 1.25
Laminin binds specifically to sulfated glycolipids. Proc Natl Acad Sci U S A (1985) 1.25
Gastrointestinal safety of nitric oxide-derived aspirin is related to inhibition of ICE-like cysteine proteases in rats. Gastroenterology (1999) 1.24
Sequences at the 3' ends of yeast viral dsRNAs: proposed transcriptase and replicase initiation sites. Nucleic Acids Res (1981) 1.24
Thrombospondin-1: a physiological regulator of nitric oxide signaling. Cell Mol Life Sci (2008) 1.23
Adrenomedullin expression in human tumor cell lines. Its potential role as an autocrine growth factor. J Biol Chem (1996) 1.23
Regulation of transforming growth factor beta1 by nitric oxide. Cancer Res (1999) 1.23
Enhanced anti-inflammatory effects of a nitric oxide-releasing derivative of mesalamine in rats. Gastroenterology (1999) 1.22
Binding of elastin to Staphylococcus aureus. J Biol Chem (1991) 1.21
Heparin- and sulfatide-binding peptides from the type I repeats of human thrombospondin promote melanoma cell adhesion. Proc Natl Acad Sci U S A (1992) 1.20
Skewed X-chromosome inactivation is associated with trisomy in women ascertained on the basis of recurrent spontaneous abortion or chromosomally abnormal pregnancies. Am J Hum Genet (2002) 1.20
Distinction between nitrosating mechanisms within human cells and aqueous solution. J Biol Chem (2001) 1.20
Evidence for direct inhibition of de novo purine synthesis in human MCF-7 breast cells as a principal mode of metabolic inhibition by methotrexate. J Biol Chem (1987) 1.19
Hypoxic mammalian cell radiosensitization by nitric oxide. Cancer Res (1993) 1.17
Determination of nitric oxide using fluorescence spectroscopy. Methods Enzymol (1996) 1.17
Inhibition by nitric oxide of the repair protein, O6-methylguanine-DNA-methyltransferase. Carcinogenesis (1994) 1.17
Toll-like receptor alterations in myelodysplastic syndrome. Leukemia (2013) 1.16
HIV envelope protein-induced neuronal damage and retardation of behavioral development in rat neonates. Brain Res (1993) 1.15
An NO derivative of ursodeoxycholic acid protects against Fas-mediated liver injury by inhibiting caspase activity. Proc Natl Acad Sci U S A (2001) 1.14
Nitrosative capacity of macrophages is dependent on nitric-oxide synthase induction signals. J Biol Chem (2000) 1.14
High affinity receptors for bombesin/GRP-like peptides on human small cell lung cancer. Life Sci (1985) 1.14
In vivo radiation protection by nitric oxide modulation. Cancer Res (1994) 1.13
NO-aspirin protects from T cell-mediated liver injury by inhibiting caspase-dependent processing of Th1-like cytokines. Gastroenterology (2000) 1.13
Identification of an alpha(3)beta(1) integrin recognition sequence in thrombospondin-1. J Biol Chem (1999) 1.13
Inhibition of aryl hydrocarbon-induced cytochrome P-450 1A1 enzyme activity and CYP1A1 expression by resveratrol. Mol Pharmacol (1999) 1.12
Increased AP-1 activity in drug resistant human breast cancer MCF-7 cells. Breast Cancer Res Treat (1999) 1.12
Regulation of insulin secretion and blood glucose metabolism by adrenomedullin. Endocrinology (1996) 1.12
Cyclooxygenase-independent chemoprevention with an aspirin derivative in a rat model of colonic adenocarcinoma. Life Sci (1998) 1.11
Neuromedin B is present in lung cancer cell lines. Cancer Res (1992) 1.11